Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes

Adipose tissue dysregulation has a major role in various human diseases. The peroxisome proliferator-activated receptor- γ (PPAR γ ) is a key regulator of adipocyte differentiation and function, as well as a target of insulin-sensitizing drugs. The Hsp90 chaperone stabilizes a diverse set of signali...

Full description

Saved in:
Bibliographic Details
Published inCell death and differentiation Vol. 20; no. 12; pp. 1654 - 1663
Main Authors Nguyen, M T, Csermely, P, Sőti, C
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2013
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Adipose tissue dysregulation has a major role in various human diseases. The peroxisome proliferator-activated receptor- γ (PPAR γ ) is a key regulator of adipocyte differentiation and function, as well as a target of insulin-sensitizing drugs. The Hsp90 chaperone stabilizes a diverse set of signaling ‘client’ proteins, thereby regulates various biological processes. Here we report a novel role for Hsp90 in controlling PPAR γ stability and cellular differentiation. Specifically, we show that the Hsp90 inhibitors geldanamycin and novobiocin efficiently impede the differentiation of murine 3T3-L1 preadipocytes. Geldanamycin at higher concentrations also inhibits the survival of both developing and mature adipocytes, respectively. Further, Hsp90 inhibition disrupts an Hsp90-PPAR γ complex, leads to the destabilization and proteasomal degradation of PPAR γ , and inhibits the expression of PPAR γ target genes, identifying PPAR γ as an Hsp90 client. A similar destabilization of PPAR γ and a halt of adipogenesis also occur in response to protein denaturing stresses caused by a single transient heat-shock or proteasome inhibition. Recovery from stress restores PPAR γ stability and adipocyte differentiation. Thus, our findings reveal Hsp90 as a critical stress-responsive regulator of adipocyte biology and offer a potential therapeutic target in obesity and the metabolic syndrome.
ISSN:1350-9047
1476-5403
DOI:10.1038/cdd.2013.129